title: FiberNet--a new embolic protection device for carotid artery stenting.
abstract: BACKGROUND
  Though distal filter protection during carotid stenting reduces the risk of cerebrovascular events, periprocedural stroke remains a risk despite their broad usage. This observation may be related to the pore size of common filters. The FiberNet distal filter system is unique by its very small pore size (40 µm) as well as its low profile and flexibility. Little data is available regarding the clinical performance and safety of this device.
  
  
  OBJECTIVE
  The aim was the evaluation of the safety of the FiberNet embolic protection system during carotid artery stenting.
  
  
  METHODS
  All consecutive patients treated with carotid stenting at our institution using the FiberNet device were systematically followed. Primary endpoint was the rate of all death and stroke within 30 days of the procedure.
  
  
  RESULTS
  Carotid artery stenting using the FiberNet embolic protection system was performed in 54 patients. The procedure was technical successful in all patients. Three patients (5.5%) had a TIA. Amauosis fugax occurred in two patients (3.7%). One patient (1.9%) had a minor stroke with hemiparesis of the left arm and face which resolved completely within 48 hr after the procedure. No patient died or suffered a major stroke.
  
  
  CONCLUSIONS
  The safety and feasibility of the FiberNet distal protection system appears to be at least equivalent to that reported in studies using conventional distal filter protection.
authors.affiliation: CardioVascular Center Frankfurt, Frankfurt, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Bauer
authors.forename: J
authors.initials: J
authors.lastname: Franke
authors.forename: S C
authors.initials: SC
authors.lastname: Bertog
authors.forename: V
authors.initials: V
authors.lastname: Woerner
authors.forename: S
authors.initials: S
authors.lastname: Ghasemzadeh-Asl
authors.forename: H
authors.initials: H
authors.lastname: Sievert
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020757:Amaurosis Fugax / Q000209:etiology / Q000517:prevention & control; D017130:Angioplasty / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D002340:Carotid Artery Diseases / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D057505:Embolic Protection Devices; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011474:Prosthesis Design; D012307:Risk Factors; D015607:Stents; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
keywords: cerebrovascular accident; cerebrovascular disease; complications adult cath/intervention; diabetes; hypertension